David Fischel

David Fischel has served as Chairman and CEO of Stereotaxis since 2017, leading the Company’s efforts to pioneer advanced robotic technologies and digital solutions that improve interventional medicine. He has served for over fifteen years as Principal at DAFNA Capital Management, LLC, a healthcare investment firm focused on biotechnology and medical device innovations. Mr. Fischel completed his B.S. magna cum laude in Applied Mathematics at the University of California at Los Angeles and received his MBA from Bar-Ilan University in Tel Aviv. He is a Certified Public Accountant, Chartered Financial Analyst and Chartered Alternative Investment Analyst.